Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Orchestra BioMed Holdings, Inc. (OBIO) had Normalized Pre-Tax Income of $-23.80M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$0.09M |
|
$-24.08M |
|
$0.03M |
|
$0.06M |
|
$22.44M |
|
$-22.36M |
|
$-1.40M |
|
$-23.75M |
|
|
Normalized Pre-Tax Income |
$-23.80M |
$-23.75M |
|
$-23.75M |
|
$-23.75M |
|
$-23.80M |
|
$-22.36M |
|
$-22.20M |
|
63.81M |
|
63.81M |
|
$-0.38 |
|
$-0.38 |
|
| Balance Sheet Financials | |
$111.24M |
|
$2.04M |
|
$4.46M |
|
$115.70M |
|
$13.47M |
|
$34.84M |
|
$82.91M |
|
$96.38M |
|
$19.32M |
|
$19.32M |
|
$19.32M |
|
60.10M |
|
| Cash Flow Statement Financials | |
$-41.50M |
|
$-12.99M |
|
$40.27M |
|
$34.69M |
|
$20.47M |
|
$-14.22M |
|
$5.36M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.26 |
|
-- |
|
-- |
|
0.64 |
|
1.80 |
|
71.59% |
|
-25404.55% |
|
-25404.55% |
|
-- |
|
-26994.32% |
|
-27362.50% |
|
$-41.94M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
0.10 |
|
1.73 |
|
52.16 |
|
-122.94% |
|
-122.94% |
|
-20.53% |
|
-43.86% |
|
$0.32 |
|
$-0.66 |
|
$-0.65 |
|